Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Research groups

Suzan Hammond


Academic Researcher

As a post-doctoral researcher and Fulford junior research fellow in the laboratory of Matthew Wood, I am involved in translational research for both Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA). Both disorders are treatable with splice switching oligonucleotides to correct genetic mutations. My focus is the targeted delivery of these therapies to skeletal muscle and central nervous system tissues, two tissues difficult to treat.

My PhD training was in the field of SMA at the Northwestern University. In this lab we developed several new lines of mice including an inducible line for early onset SMA to study disease pathology. Since coming to the Wood lab my work has focused on improving and designing new therapies for DMD and SMA. Over the past six years the Wood lab has used peptide delivery systems for improving the efficacy of antisense oligonucleotide therapies. I am currently translating this work into the SMA field.